Study of Akt Inhibitor MK2206 in Patients With Relapsed Lymphoma
收藏NIAID Data Ecosystem2026-03-06 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2099453
下载链接
链接失效反馈官方服务：
资源简介：
This phase II clinical trial studies how well Akt inhibitor MK2206 works in treating patients with relapsed lymphoma. Akt inhibitor MK2206 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
创建时间：
2010-12-15
